Bellerophon Therapeutics, Inc. (BLPH) Financials
Stock symbol BLPH is outdated, potentially delisted? Maybe it is available on other exchange?
BLPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 5.0 million | 1.3 million |
| June 30, 2023 | 11.2 million | 5.6 million |
| March 31, 2023 | 16.0 million | 5.4 million |
| Dec. 31, 2022 | 7.9 million | 5.4 million |
BLPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -6.3 million | 21000 |
| June 30, 2023 | -4.9 million | 133000 |
| March 31, 2023 | 3.3 million | 264000 |
| Dec. 31, 2022 | -4.4 million | 162000 |
BLPH Net Income
No data available :(
BLPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 4.4 million | - | - |
| June 30, 2023 | 10.6 million | - | - |
| March 31, 2023 | 15.2 million | - | 8000 |
| Dec. 31, 2022 | 6.9 million | - | 203000 |
BLPH Shares Outstanding
BLPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 544000 | 1.6 million | - |
| June 30, 2023 | - | 2.9 million | 2.4 million | - |
| March 31, 2023 | - | 2.6 million | 1.6 million | - |
| Dec. 31, 2022 | - | 3.7 million | 1.4 million | - |
BLPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | - |
| June 30, 2023 | - | - |
| March 31, 2023 | 5.6 million | - |
| Dec. 31, 2022 | - | - |
BLPH
Price: $0.01
52 week price:
Earnings Per Share: -0.89 USD
P/E Ratio: -0.07
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18100
Ebitda: -6.1 millionMarket Capitalization: 232419